Izaflortaucipir F-18
- Generic Name
- Izaflortaucipir F-18
[18F]PI-2620 Phase 3 Histopathological Study
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Life Molecular Imaging Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT05641688
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸Banner Sun Health Research Institute, Sun City, Arizona, United States
🇺🇸UC Los Angeles, Los Angeles, California, United States
Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Life Molecular Imaging SA
- Target Recruit Count
- 18
- Registration Number
- NCT05337774
- Locations
- 🇺🇸
Walter Reed National Military Medical Center (WRNMMC), Bethesda, Maryland, United States
Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease
Phase 1
Completed
- Conditions
- Alzheimer Disease (AD)
- Interventions
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04566003
- Locations
- 🇺🇸
Invicro, a Konica Minolta company, New Haven, Connecticut, United States
Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease
Phase 2
Completed
- Conditions
- Cognitively NormalMild Cognitive ImpairmentAlzheimer Disease
- Interventions
- First Posted Date
- 2019-04-04
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- Jae Seung Kim
- Target Recruit Count
- 84
- Registration Number
- NCT03903211
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain
Early Phase 1
Completed
- Conditions
- Healthy VolunteerFrontotemporal DementiaAlzheimer DiseaseParkinson Disease
- Interventions
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2020-12-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT03510572
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath